Full Press Release Details
of Director's Interest Notice
of Director's Interest Notice
or documents not available now must be given to ASX as soon as available.
Information and documents given to ASX become ASX's property and may be made
| Name of Entity: | Prana Biotechnology Limited |
| ACN: | 080 699 065 |
entity) give ASX the following information under listing rule 3.19A.2 and as
agent for the director for the purposes of section 205G of the Corporations
| Name of Director: | Geoffrey Kempler |
| Date of Last Notice: | 18 December 2006 |
1 - Change of director's relevant interests in securities
case of a trust, this includes interests in the trust made available by the
responsible entity of the trust
case of a company, interests which come within paragraph (i) of the definition
of "notifiable interest of a director" should be disclosed in this
| Direct or indirect interest | Direct | |||
| Nature of indirect interest (including registered holder) | - | |||
| Date of change | 14 th March 2008 | |||
| No. of securities held prior to change | Shares | Options | ||
| Direct | 30,000 | 2,000,000 | ||
| Indirect | 17,025,000 | - | ||
| Total | 17,055,000 | 2,000,000 | ||
| Class | Options | |||
| Number acquired | Shares | Options | ||
| Direct | - | 1,000,000 | ||
| Indirect | - | - | ||
| Total | - | 1,000,000 | ||
| Number disposed | NIL | |||
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | NIL |
| No. of securities held prior to change | Shares | Options | ||
| Direct | 30,000 | 3,000,000 | ||
| Indirect | 17,025,000 | - | ||
| Total | 17,055,000 | 3,000,000 | ||
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | Issued under the Prana Biotechnology Limited Employee Share & Option Incentive Plan, as per Resolution 3 of the Annual General Meeting of Prana Biotechnology Limited held on 20 th December 2007. |
2 - Change of director's interests in contracts
case of a company, interests which come within paragraph (ii) of the definition
of "notifiable interest of a director" should be disclosed in this
| Detail of contract | |
| Nature of interest | |
| Name of registered holder (if issued securities) | |
| Date of change | |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | |
| Interest acquired | |
| Interest disposed | |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | |
| Interest after change |
of Director's Interest Notice
of Director's Interest Notice
or documents not available now must be given to ASX as soon as available.
Information and documents given to ASX become ASX's property and may be made
| Name of Entity: | Prana Biotechnology Limited |
| ACN: | 080 699 065 |
entity) give ASX the following information under listing rule 3.19A.2 and
agent for the director for the purposes of section 205G of the Corporations
| Name of Director: | George Mihaly |
| Date of Last Notice: | 18 December 2006 |
1 - Change of director's relevant interests in securities
case of a trust, this includes interests in the trust made available by the
responsible entity of the trust
case of a company, interests which come within paragraph (i) of the definition
of "notifiable interest of a director" should be disclosed in this
| Direct or indirect interest | Direct | |||
| Nature of indirect interest (including registered holder) | - | |||
| Date of change | 14 th March 2008 | |||
| No. of securities held prior to change | Shares | Options | ||
| Direct | 166,666 | 600,000 | ||
| Indirect | 60,000 | - | ||
| Total | 226,666 | 600,000 | ||
| Class | Options | |||
| Number acquired | Shares | Options | ||
| Direct | - | 350,000 | ||
| Indirect | - | - | ||
| Total | - | 350,000 | ||
| Number disposed | NIL | |||
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | NIL |
| No. of securities held prior to change | Shares | Options | ||
| Direct | 166,666 | 950,000 | ||
| Indirect | 60,000 | - | ||
| Total | 226,666 | 950,000 | ||
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | Issued under the Prana Biotechnology Limited Employee Share & Option Incentive Plan, as per Resolution 3 of the Annual General Meeting of Prana Biotechnology Limited held on 20 th December 2007. |
2 - Change of director's interests in contracts
case of a company, interests which come within paragraph (ii) of the definition
of "notifiable interest of a director" should be disclosed in this
| Detail of contract | |
| Nature of interest | |
| Name of registered holder (if issued securities) | |
| Date of change | |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | |
| Interest acquired | |
| Interest disposed | |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | |
| Interest after change |
of Director's Interest Notice
of Director's Interest Notice
or documents not available now must be given to ASX as soon as available.
Information and documents given to ASX become ASX's property and may be made
| Name of Entity: | Prana Biotechnology Limited |
| ACN: | 080 699 065 |
entity) give ASX the following information under listing rule 3.19A.2 and
agent for the director for the purposes of section 205G of the Corporations
| Name of Director: | Peter Marks |
| Date of Last Notice: | 18 December 2006 |
1 - Change of director's relevant interests in securities
case of a trust, this includes interests in the trust made available by
responsible entity of the trust
case of a company, interests which come within paragraph (i) of the definition
of "notifiable interest of a director" should be disclosed in this
| Direct or indirect interest | Direct | |||
| Nature of indirect interest (including registered holder) | - | |||
| Date of change | 14 th March 2008 | |||
| No. of securities held prior to change | Shares | Options | ||
| Direct | - | 300,000 | ||
| Indirect | 43,111 | 300,000 | ||
| Total | 43,111 | 600,000 | ||
| Class | Options | |||
| Number acquired | Shares | Options | ||
| Direct | - | 350,000 | ||
| Indirect | - | - | ||
| Total | - | 350,000 | ||
| Number disposed | NIL | |||
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | NIL |
| No. of securities held prior to change | Shares | Options | ||
| Direct | - | 650,000 | ||
| Indirect | 43,111 | 300,000 | ||
| Total | 43,111 | 950,000 | ||
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | Issued under the Prana Biotechnology Limited Employee Share & Option Incentive Plan, as per Resolution 3 of the Annual General Meeting of Prana Biotechnology Limited held on 20 th December 2007. |
2 - Change of director's interests in contracts
case of a company, interests which come within paragraph (ii) of the definition
of "notifiable interest of a director" should be disclosed in this
| Detail of contract | |
| Nature of interest | |
| Name of registered holder (if issued securities) | |
| Date of change | |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | |
| Interest acquired | |
| Interest disposed | |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | |
| Interest after change |
of Director's Interest Notice
of Director's Interest Notice
or documents not available now must be given to ASX as soon as available.
Information and documents given to ASX become ASX's property and may be made
| Name of Entity: | Prana Biotechnology Limited |
| ACN: | 080 699 065 |
entity) give ASX the following information under listing rule 3.19A.2 and as
agent for the director for the purposes of section 205G of the Corporations
| Name of Director: | Brian Meltzer |
| Date of Last Notice: | 18 December 2006 |
1 - Change of director's relevant interests in securities
case of a trust, this includes interests in the trust made available by the
responsible entity of the trust
case of a company, interests which come within paragraph (i) of the definition
of "notifiable interest of a director" should be disclosed in this
| Direct or indirect interest | Indirect | |||
| Nature of indirect interest (including registered holder) | Director related entity | |||
| Date of change | 14 th March 2008 | |||
| No. of securities held prior to change | Shares | Options | ||
| Direct | - | - | ||
| Indirect | 326,666 | 600,000 | ||
| Total | 326,666 | 600,000 | ||
| Class | Options | |||
| Number acquired | Shares | Options | ||
| Direct | - | - | ||
| Indirect | - | 350,000 | ||
| Total | - | 350,000 | ||
| Number disposed | NIL | |||
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | NIL |
| No. of securities held prior to change | Shares | Options | ||
| Direct | - | - | ||
| Indirect | 326,666 | 950,000 | ||
| Total | 326,666 | 950,000 | ||
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | Issued under the Prana Biotechnology Limited Employee Share & Option Incentive Plan, as per Resolution 3 of the Annual General Meeting of Prana Biotechnology Limited held on 20 th December 2007. |
2 - Change of director's interests in contracts
case of a company, interests which come within paragraph (ii) of the definition
of "notifiable interest of a director" should be disclosed in this
| Detail of contract | |
| Nature of interest | |
| Name of registered holder (if issued securities) | |
| Date of change | |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | |
| Interest acquired | |
| Interest disposed | |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | |
| Interest after change |